Cart
sales@molnova.com
SC-806
CAS No. 216505-89-4
SC-806( SC 806 | SC806 )
Catalog No. M13454 CAS No. 216505-89-4
A potent, orally active p38 MAPK inhibitor with IC50 of 50 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSC-806
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, orally active p38 MAPK inhibitor with IC50 of 50 nM.
-
DescriptionA potent, orally active p38 MAPK inhibitor with IC50 of 50 nM, significantly decreases incidence of arthritis in mouse collagen-induced arthritis.
-
In Vitro——
-
In Vivo——
-
SynonymsSC 806 | SC806
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216505-89-4
-
Formula Weight353.854
-
Molecular FormulaC19H20ClN5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name1-(5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)-4-methylpiperazine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Graneto MJ, et al. J Med Chem. 2007 Nov 15;50(23):5712-9.
molnova catalog
related products
-
CMPD-1
A potent, selective, non-ATP-competitive inhibitor of p38α-mediated MK2a phosphorylation with apparent Ki of 330 nM.
-
SKLB-163
SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
-
SSK1
SSK1 is a compound that selectively kills senescent cells and is a precursor for β-galactosidase, which can reduce the inflammatory response of the body. SSK1 can activate the phosphorylation of p38 MAPK and MKK3/MKK6 in senescent cells, and promote mitochondrial DNA damage in senescent cells.
